Secondary metastasis resection after biomarker-stratified first-line treatment of metastatic colorectal carcinomaInterim analysis of the IVOPAK II study with a risk-benefit assessment of secondary metastatic resection
- DOI
- 10.1159/ocl/aebag025
- Published
- 2026-10-21
- Container
- Oncology
- Publisher
- S. Karger AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1159/ocl/aebag025,
title = {Secondary metastasis resection after biomarker-stratified first-line treatment of metastatic colorectal carcinomaInterim analysis of the IVOPAK II study with a risk-benefit assessment of secondary metastatic resection},
author = {Axel Wein and Susanne Merkel and Markus Eckstein and Juergen Siebler and Kerstin Wolff and Dagmar Busse and Maximilian Gerner and Axel Schmid and Peter Anhut and Stephan Kersting and Arndt Hartmann and Markus Neurath and Robert Gruetzmann and Christian Krautz},
year = {2026},
journal = {Oncology},
doi = {10.1159/ocl/aebag025},
url = {https://doi.org/10.1159/ocl/aebag025}
}RIS
TY - JOUR TI - Secondary metastasis resection after biomarker-stratified first-line treatment of metastatic colorectal carcinomaInterim analysis of the IVOPAK II study with a risk-benefit assessment of secondary metastatic resection AU - Axel Wein AU - Susanne Merkel AU - Markus Eckstein AU - Juergen Siebler AU - Kerstin Wolff AU - Dagmar Busse AU - Maximilian Gerner AU - Axel Schmid AU - Peter Anhut AU - Stephan Kersting AU - Arndt Hartmann AU - Markus Neurath AU - Robert Gruetzmann AU - Christian Krautz PY - 2026 JO - Oncology DO - 10.1159/ocl/aebag025 UR - https://doi.org/10.1159/ocl/aebag025 ER -
APA
Wein, A., Merkel, S., Eckstein, M., Siebler, J., Wolff, K., Busse, D., Gerner, M., Schmid, A., Anhut, P., Kersting, S., Hartmann, A., Neurath, M., Gruetzmann, R., & Krautz, C. (2026). Secondary metastasis resection after biomarker-stratified first-line treatment of metastatic colorectal carcinomaInterim analysis of the IVOPAK II study with a risk-benefit assessment of secondary metastatic resection. Oncology. https://doi.org/10.1159/ocl/aebag025
Source records
- crossref · retrieved 2026-11-10T07:48:08.903Z